Source:http://linkedlifedata.com/resource/pubmed/id/19926031
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2009-11-20
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1474-4457
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
724-5
|
pubmed:meshHeading |
pubmed-meshheading:19926031-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:19926031-Drug Administration Schedule,
pubmed-meshheading:19926031-HIV Infections,
pubmed-meshheading:19926031-Humans,
pubmed-meshheading:19926031-Proportional Hazards Models,
pubmed-meshheading:19926031-Risk Factors,
pubmed-meshheading:19926031-United States
|
pubmed:year |
2009
|
pubmed:articleTitle |
Relative risk of death in the SMART study.
|
pubmed:publicationType |
Letter,
Comment
|